Bionano Genomics (NasdaqCM:BNGO) Q4 2025 Earnings call March 23, 2026 04:30 PM ET Company ParticipantsErik Holmlin - President and CEOMark Adamchak - VP of AccountingWebb Campbell - VPConference Call ParticipantsYi Chen - Managing Director and Senior AnalystOperatorGood day, and welcome to the Bionano Q4 and full year 2025 earnings conference call. Today's conference is being recorded. At this time, I would like to turn the conference over to Webb Campbell from Gilmartin Group. Please go ahead.Webb Campbell ...

Castle Biosciences (NasdaqGM:CSTL) Update / briefing March 23, 2026 04:30 PM ET Company ParticipantsCamilla Zuckero - VP of Investor Relations and Corporate AffairsCatherine Schulte - Director of Life Sciences Equity ResearchDerek Maetzold - President and CEOMason Carrico - Managing Director of Medical Technology Equity ResearchMatthew Goldberg - SVP of MedicalMichael Guenther - Surgical OncologistConference Call ParticipantsCarlos Penikis - Senior Equity Research AnalystThomas Flaten - Senior Equity Resear ...

Bionano Genomics (NasdaqCM:BNGO) Q4 2025 Earnings call March 23, 2026 04:30 PM ET Speaker2Good day, and welcome to the Bionano fourth quarter and full year 2025 earnings conference call. Today's conference is being recorded. At this time, I would like to turn the conference over to Webb Campbell from Gilmartin Group. Please go ahead.Speaker3Thank you, Carmen, and good afternoon, everyone. Welcome to Bionano's fourth quarter and full year 2025 financial results conference call. On the call today is Dr. Erik ...

Rumble (NasdaqGM:RUM) FY Conference March 23, 2026 04:00 PM ET Company ParticipantsChris Pavlovski - Founder and CEOConference Call ParticipantsRohit Kulkarni - Managing Director and Senior Research AnalystRohit KulkarniOkay. Thank you for joining us. My name is Rohit Kulkarni. I'm the Internet Analyst here at Roth Capital Partners. But more importantly, thanks, Chris Pavlovski, Founder and CEO of Rumble. Rumble has grown into one of the largest independent video platforms globally, built on the foundation ...

Earnings Call 4Q25 1 Disclaimer This presentation speaks at the date hereof and AGI Inc (the "Company") is under no obligation to update or keep current the information contained in this presentation. Any information expressed herein is subject to change without notice. Any market or other third-party data included in this presentation has been obtained by the Company from third-party sources. While the Company has compiled and extracted the market data, it can provide no assurances of the accuracy and comp ...

Q4'25 & FY25 Financial Results Webcast & Call March 23, 2026 Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this presentation, including statements regarding our future results of operations or financial condition, business strategy and plans, and objectives of management for ...

CervoMed (NasdaqCM:CRVO) FY Conference March 23, 2026 03:00 PM ET Company ParticipantsMatt Winton - CCO and CBOModeratorGood afternoon, everyone. I am Boobalan Pachaiyappan, Managing Director and Senior Biotech Analyst at Roth Capital Partners. With me today is Matt Winton, who is the Chief Commercial Officer and Chief Business Officer of CervoMed. For those who are new to the story, CervoMed is developing oral drugs for neurodegenerative diseases, including dementia with Lewy bodies, ALS, and FTD, and so o ...

Prenetics Global (NasdaqGM:PRE) FY Conference March 23, 2026 03:00 PM ET Company ParticipantsDanny Yeung - CEO and Co-founderJason Wersland - FounderNate Raabe - Managing PartnerShadi Bakour - Co-founder and CEOShahab Elmi - Founder and CEOConference Call ParticipantsNone - AnalystNone - AnalystNate RaabeAll right, we're missing a panelist here. I think he's talking with Mr. Johnson out there, so he may join us later. We're gonna go ahead and get started here. There'll be people trickling in. My name is Nat ...

Astera Labs (NasdaqGS:ALAB) FY Conference March 23, 2026 02:30 PM ET Company ParticipantsNick Aberle - VP of Finance, Investor Relations, and TreasurerConference Call ParticipantsSuji Desilva - Managing Director and Senior Research AnalystNone - AnalystNone - AnalystSuji DesilvaI'm a systems analyst at Roth. Usually, you know, I have to go back and look at somebody's bio when I'm meeting them, but I've known Nick most of his career. We started talking to each other when he was working at Netlogic and Broadc ...

Cronos Group (NasdaqGM:CRON) FY Conference March 23, 2026 02:30 PM ET Company ParticipantsMike Gorenstein - Chairman, President, and CEOConference Call ParticipantsNone - AnalystNoneIn a minute. Yeah, I think the clock is still. There it is. All right. I'm ready if you're ready. All right. Good morning, everybody. This is the consumer track. We're in the blue room, where we're about to hear from Cronos Group Chairman and CEO Mike Gorenstein. Mike, thank you for being here. Cronos is a leading cannabis LP, w ...